FDA Lacks Data To Back Funding Requests: Report

Law360, New York (August 27, 2009, 4:03 PM EDT) -- The U.S. Food and Drug Administration is unable to build sufficient funding requests because of internal data collection failures, leaving the agency critically short-staffed for important tasks such as tracking adverse event reports, according to the U.S. Government Accountability Office.

The government spending watchdog published a report Monday claiming that, as the FDA's annual medical products budget becomes increasingly tied to user fees collected from pharmaceutical manufacturers, the agency is having difficulty finding money to support programs not paid for through user fees, including adverse event...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.